Skip to main content
Top
Published in: Sleep and Breathing 1/2018

01-03-2018 | Sleep Breathing Physiology and Disorders • Original Article

Pulmonary surfactant-associated proteins and inflammatory factors in obstructive sleep apnea

Authors: Dongmei Lu, Ayiniger Abulimiti, Ting Wu, Ailigen Abudureyim, Nanfang Li

Published in: Sleep and Breathing | Issue 1/2018

Login to get access

Abstract

Purpose

Pulmonary surfactant (PS) plays roles in promoting the removal of the liquid, host defense, and immune regulation in the tracheal, bronchial, and alveoli epithelium. PS protein expression level can be regulated by oxygen levels and related free radicals. Obstructive sleep apnea (OSA) is featured with oxygen free radical production for damaging epithelial tissues and thus may affect PS production. The study was to explore the relationship between PS protein and OSA severity.

Methods

We collected serum and bronchoalveolar lavage fluid (BALF) samples from 35 OSA patients and 22 healthy subjects. PS-associated proteins and inflammatory factors, including surfactant proteins, HIF-1α, NF-κB, and IL-6, were analyzed. Regression analysis was performed to reveal the relationship between biochemical factors and clinical indexes recorded during PSG monitor.

Results

Lower BALF and surfactant protein (except surfactant protein C or SPC) levels occurred in OSA patients (all p < 0.05 compared to control group). A strongly negative correlation was found between surfactant protein with apnea-hypopnea index (AHI) and other sleeping indexes including ODI3 and ODI4. Similar patterns were found in serum samples, which were strongly correlated with BALF counterparts. Surfactant proteins were further found to have negative regression with inflammatory factors such as HIF-1α, NF-κB, and IL-6.

Conclusions

This study established the relationship between PS-related protein with severity of OSA, plus their relationship with inflammatory factors. Our results provided possibly novel markers in general circulation for disease evaluation of OSA.
Literature
1.
go back to reference Speer CP, Sweet DG, Halliday HL (2013) Surfactant therapy: past, present and future. Early Hum Dev 89(Suppl 1):S22–S24CrossRefPubMed Speer CP, Sweet DG, Halliday HL (2013) Surfactant therapy: past, present and future. Early Hum Dev 89(Suppl 1):S22–S24CrossRefPubMed
2.
go back to reference Andreeva AV, Kutuzov MA, Voyno-Yasenetskaya TA (2007) Regulation of surfactant secretion in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 293:L259–L271CrossRefPubMed Andreeva AV, Kutuzov MA, Voyno-Yasenetskaya TA (2007) Regulation of surfactant secretion in alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 293:L259–L271CrossRefPubMed
3.
go back to reference Vives MF, Caspar-Bauguil S, Aliouat EM, Escamilla R, Perret B, Dei-Cas E, Prevost MC (2008) Hypobaric hypoxia-related impairment of pulmonary surfactant proteins A and D did not favour pneumocystis carinii Frenkel 1999 growth in non-immunocompromised rats. Parasite 15:53–64CrossRefPubMed Vives MF, Caspar-Bauguil S, Aliouat EM, Escamilla R, Perret B, Dei-Cas E, Prevost MC (2008) Hypobaric hypoxia-related impairment of pulmonary surfactant proteins A and D did not favour pneumocystis carinii Frenkel 1999 growth in non-immunocompromised rats. Parasite 15:53–64CrossRefPubMed
4.
go back to reference White CW, Greene KE, Allen CB, Shannon JM (2001) Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia. Am J Respir Cell Mol Biol 25:51–59CrossRefPubMed White CW, Greene KE, Allen CB, Shannon JM (2001) Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia. Am J Respir Cell Mol Biol 25:51–59CrossRefPubMed
5.
go back to reference Ito Y, Ahmad A, Kewley E, Mason RJ (2011) Hypoxia-inducible factor regulates expression of surfactant protein in alveolar type II cells in vitro. Am J Respir Cell Mol Biol 45:938–945CrossRefPubMedPubMedCentral Ito Y, Ahmad A, Kewley E, Mason RJ (2011) Hypoxia-inducible factor regulates expression of surfactant protein in alveolar type II cells in vitro. Am J Respir Cell Mol Biol 45:938–945CrossRefPubMedPubMedCentral
6.
go back to reference Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667CrossRefPubMed Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667CrossRefPubMed
7.
go back to reference Winnicki M, Shamsuzzaman A, Lanfranchi P, Accurso V, Olson E, Davison D, Somers VK (2004) Erythropoietin and obstructive sleep apnea. Am J Hypertens 17:783–786CrossRefPubMed Winnicki M, Shamsuzzaman A, Lanfranchi P, Accurso V, Olson E, Davison D, Somers VK (2004) Erythropoietin and obstructive sleep apnea. Am J Hypertens 17:783–786CrossRefPubMed
8.
go back to reference Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, Gorlach A (2007) Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18:4691–4697CrossRefPubMedPubMedCentral Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, Gorlach A (2007) Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell 18:4691–4697CrossRefPubMedPubMedCentral
9.
go back to reference Tong Q, Zheng L, Dodd-o J, Langer J, Wang D, Li D (2006) Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung. Am J Respir Cell Mol Biol 34:28–38CrossRefPubMed Tong Q, Zheng L, Dodd-o J, Langer J, Wang D, Li D (2006) Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung. Am J Respir Cell Mol Biol 34:28–38CrossRefPubMed
10.
go back to reference Liang S, Li N, Heizhati M, Yao X, Abdireim A, Wang Y, Abulikemu Z, Zhang D, Chang G, Kong J, Zhou L, Hong J, Ying T, Zhang Y (2015) What do changes in concentrations of serum surfactant proteins A and D in OSA mean? Sleep Breath 19:955–962CrossRefPubMed Liang S, Li N, Heizhati M, Yao X, Abdireim A, Wang Y, Abulikemu Z, Zhang D, Chang G, Kong J, Zhou L, Hong J, Ying T, Zhang Y (2015) What do changes in concentrations of serum surfactant proteins A and D in OSA mean? Sleep Breath 19:955–962CrossRefPubMed
11.
go back to reference Shao L, Li N, Yao X, Heizati M, Abdireim A, Wang Y, Abulikemu Z, Zhang D, Chang G, Zhou L, Hong J, Zhang Y, Kong J, Zhang X (2016) Relationship between surfactant proteins B and C and obstructive sleep apnea: is serum SP-B concentration a potential biomarker of obstructive sleep apnea? Sleep Breath 20:25–31CrossRefPubMed Shao L, Li N, Yao X, Heizati M, Abdireim A, Wang Y, Abulikemu Z, Zhang D, Chang G, Zhou L, Hong J, Zhang Y, Kong J, Zhang X (2016) Relationship between surfactant proteins B and C and obstructive sleep apnea: is serum SP-B concentration a potential biomarker of obstructive sleep apnea? Sleep Breath 20:25–31CrossRefPubMed
12.
go back to reference Kirkness JP, Madronio M, Stavrinou R, Wheatley JR, and Amis TC: Relationship between surface tension of upper airway lining liquid and upper airway collapsibility during sleep in obstructive sleep apnea hypopnea syndrome. J Appl Physiol (1985) 2003; 95: 1761–6 Kirkness JP, Madronio M, Stavrinou R, Wheatley JR, and Amis TC: Relationship between surface tension of upper airway lining liquid and upper airway collapsibility during sleep in obstructive sleep apnea hypopnea syndrome. J Appl Physiol (1985) 2003; 95: 1761–6
13.
go back to reference Kirkness JP, Madronio M, Stavrinou R, Wheatley JR, Amis TC (2005) Surface tension of upper airway mucosal lining liquid in obstructive sleep apnea/hypopnea syndrome. Sleep 28:457–463CrossRefPubMed Kirkness JP, Madronio M, Stavrinou R, Wheatley JR, Amis TC (2005) Surface tension of upper airway mucosal lining liquid in obstructive sleep apnea/hypopnea syndrome. Sleep 28:457–463CrossRefPubMed
14.
go back to reference Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI (2009) Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 32:447–470CrossRefPubMedPubMedCentral Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI (2009) Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 32:447–470CrossRefPubMedPubMedCentral
15.
go back to reference Cochrane CG, Spragg R, and Revak SD: Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 1983; 71: 754–761 Cochrane CG, Spragg R, and Revak SD: Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 1983; 71: 754–761
17.
go back to reference Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S (2000) Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162:1109–1114CrossRefPubMed Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S (2000) Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 162:1109–1114CrossRefPubMed
18.
go back to reference Stapleton RD, Dixon AE, Parsons PE, Ware LB, Suratt BT (2010) The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest 138:568–577CrossRefPubMedPubMedCentral Stapleton RD, Dixon AE, Parsons PE, Ware LB, Suratt BT (2010) The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest 138:568–577CrossRefPubMedPubMedCentral
19.
go back to reference Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, Krug N, Roepcke S, Lauer G, Elmlinger M, Hohlfeld JM (2011) Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res 12:29CrossRefPubMedPubMedCentral Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, Krug N, Roepcke S, Lauer G, Elmlinger M, Hohlfeld JM (2011) Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. Respir Res 12:29CrossRefPubMedPubMedCentral
20.
go back to reference Massaro GD, Massaro D (1983) Morphologic evidence that large inflations of the lung stimulate secretion of surfactant. Am Rev Respir Dis 127:235–236PubMed Massaro GD, Massaro D (1983) Morphologic evidence that large inflations of the lung stimulate secretion of surfactant. Am Rev Respir Dis 127:235–236PubMed
21.
go back to reference Sin DD, Pahlavan PS, Man SF (2008) Surfactant protein D: a lung specific biomarker in COPD? Ther Adv Respir Dis 2:65–74CrossRefPubMed Sin DD, Pahlavan PS, Man SF (2008) Surfactant protein D: a lung specific biomarker in COPD? Ther Adv Respir Dis 2:65–74CrossRefPubMed
22.
go back to reference Wirtz HR, Dobbs LG (1990) Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 250:1266–1269CrossRefPubMed Wirtz HR, Dobbs LG (1990) Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells. Science 250:1266–1269CrossRefPubMed
23.
go back to reference Wirtz H, Schmidt M (1992) Ventilation and secretion of pulmonary surfactant. Clin Investig 70:3–13CrossRefPubMed Wirtz H, Schmidt M (1992) Ventilation and secretion of pulmonary surfactant. Clin Investig 70:3–13CrossRefPubMed
24.
go back to reference Aderibigbe AO, Thomas RF, Mercer RR, Auten RL Jr (1999) Brief exposure to 95% oxygen alters surfactant protein D and mRNA in adult rat alveolar and bronchiolar epithelium. Am J Respir Cell Mol Biol 20:219–227CrossRefPubMed Aderibigbe AO, Thomas RF, Mercer RR, Auten RL Jr (1999) Brief exposure to 95% oxygen alters surfactant protein D and mRNA in adult rat alveolar and bronchiolar epithelium. Am J Respir Cell Mol Biol 20:219–227CrossRefPubMed
25.
go back to reference Guo Y, Yang MC, Weissler JC, Yang YS (2007) PLAGL2 translocation and SP-C promoter activity—a cellular response of lung cells to hypoxia. Biochem Biophys Res Commun 360:659–665CrossRefPubMedPubMedCentral Guo Y, Yang MC, Weissler JC, Yang YS (2007) PLAGL2 translocation and SP-C promoter activity—a cellular response of lung cells to hypoxia. Biochem Biophys Res Commun 360:659–665CrossRefPubMedPubMedCentral
26.
go back to reference Braems GA, Yao LJ, Inchley K, Brickenden A, Han VK, Grolla A, Challis JR, Possmayer F (2000) Ovine surfactant protein cDNAs: use in studies on fetal lung growth and maturation after prolonged hypoxemia. Am J Physiol Lung Cell Mol Physiol 278:L754–L764CrossRefPubMed Braems GA, Yao LJ, Inchley K, Brickenden A, Han VK, Grolla A, Challis JR, Possmayer F (2000) Ovine surfactant protein cDNAs: use in studies on fetal lung growth and maturation after prolonged hypoxemia. Am J Physiol Lung Cell Mol Physiol 278:L754–L764CrossRefPubMed
27.
go back to reference Ciccone MM, Scicchitano P, Mitacchione G, Zito A, Gesualdo M, Caputo P, Damiani MF, Sassara M, Favale S, Resta O, Carratu P (2012) Is there a correlation between OSAS duration/severity and carotid intima-media thickness? Respir Med 106:740–746CrossRefPubMed Ciccone MM, Scicchitano P, Mitacchione G, Zito A, Gesualdo M, Caputo P, Damiani MF, Sassara M, Favale S, Resta O, Carratu P (2012) Is there a correlation between OSAS duration/severity and carotid intima-media thickness? Respir Med 106:740–746CrossRefPubMed
29.
go back to reference Damiani MF, Carratu P, Quaranta VN, Resta O (2012) Influence of obstructive sleep apnea on endothelial function in obese patients. Chest 141:1639 author reply 1640CrossRefPubMed Damiani MF, Carratu P, Quaranta VN, Resta O (2012) Influence of obstructive sleep apnea on endothelial function in obese patients. Chest 141:1639 author reply 1640CrossRefPubMed
30.
go back to reference He C, Chen B (2012) Sleep Related Breathing Disorders Team, Respiology Branch, Chinese Medical Association, OSA diagnosis and treatment guideline. Chinese Journal of Tuberculosis and Respiratory Diseases 35:9–12 He C, Chen B (2012) Sleep Related Breathing Disorders Team, Respiology Branch, Chinese Medical Association, OSA diagnosis and treatment guideline. Chinese Journal of Tuberculosis and Respiratory Diseases 35:9–12
31.
go back to reference KSS S, Veeramohan PH, Mathew T, S S, M C (2012) Nifedipine inhibits hypoxia induced transvascular leakage through down regulation of NFkB. Respir Physiol Neurobiol 183:26–34CrossRef KSS S, Veeramohan PH, Mathew T, S S, M C (2012) Nifedipine inhibits hypoxia induced transvascular leakage through down regulation of NFkB. Respir Physiol Neurobiol 183:26–34CrossRef
32.
go back to reference Fitzpatrick SF, Tambuwala MM, Bruning U, Schaible B, Scholz CC, Byrne A, O'Connor A, Gallagher WM, Lenihan CR, Garvey JF, Howell K, Fallon PG, Cummins EP, Taylor CT (2011) An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia. J Immunol 186:1091–1096CrossRefPubMed Fitzpatrick SF, Tambuwala MM, Bruning U, Schaible B, Scholz CC, Byrne A, O'Connor A, Gallagher WM, Lenihan CR, Garvey JF, Howell K, Fallon PG, Cummins EP, Taylor CT (2011) An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia. J Immunol 186:1091–1096CrossRefPubMed
33.
go back to reference Ciccone MM, Scicchitano P, Zito A, Cortese F, Boninfante B, Falcone VA, Quaranta VN, Ventura VA, Zucano A, Di Serio F, Damiani MF, Resta O (2014) Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules 19:1651–1662CrossRefPubMed Ciccone MM, Scicchitano P, Zito A, Cortese F, Boninfante B, Falcone VA, Quaranta VN, Ventura VA, Zucano A, Di Serio F, Damiani MF, Resta O (2014) Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in obstructive sleep apnea. Molecules 19:1651–1662CrossRefPubMed
Metadata
Title
Pulmonary surfactant-associated proteins and inflammatory factors in obstructive sleep apnea
Authors
Dongmei Lu
Ayiniger Abulimiti
Ting Wu
Ailigen Abudureyim
Nanfang Li
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 1/2018
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-017-1536-z

Other articles of this Issue 1/2018

Sleep and Breathing 1/2018 Go to the issue

Acknowledgement to Referees

Reviewer thank you 2017

Sleep Breathing Physiology and Disorders • Original Article

Combination mode of physiological signals for diagnosis of OSAS using portable monitor

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.